Valuation of a pre-sales biotech company at IPO use real option techniques and likelihood trees. Firm relies in London in Massachusetts and lists on AIM.
Products are genetically-modified rapidly-growing salmon for fish farmers and disease-prevention drugs and diagnostic kits for farmed shrimp.
PUBLICATION DATE: September 26, 2012 PRODUCT #: 213047-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
David Melcher
General Dynamics and Computer Sciences Corp.: Outsourcing the IS Function (D)
Aqua Bounty
GM In China Protected
Kerr-Mcgree
Business Proposal
SMEs and new ventures need business model sophistication
The Anticipatory Leader: How to See Sooner and Scan Wider
The Rise and Fall of Nokia
Best Buy’s Turn-Around Strategy (2013)
